{"id":734506,"date":"2025-03-05T08:00:02","date_gmt":"2025-03-05T08:00:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=734506"},"modified":"2025-03-05T08:00:02","modified_gmt":"2025-03-05T08:00:02","slug":"reus-research-rebrands-as-catakor-a-new-era-of-innovation-in-nad-enhancement","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/reus-research-rebrands-as-catakor-a-new-era-of-innovation-in-nad-enhancement_734506.html","title":{"rendered":"Reus Research Rebrands as Cata-Kor: A New Era of Innovation in NAD+ Enhancement"},"content":{"rendered":"
\"Reus<\/a><\/div>\n
Pioneering the Future of NAD+ Supplementation with Advanced LipoNAD+ Technology and a Renewed Commitment to Scientific Excellence.<\/div>\n

Miami, FL – Mar 5, 2025 – <\/strong>Reus Research, a leader in NAD+ supplementation and longevity science, is officially rebranding as Cata-Kor<\/a>, marking a bold step forward in its commitment to innovation, scientific integrity, and superior health solutions.<\/p>\n

“We are evolving beyond our original identity to reflect our advancements in longevity science while staying true to our mission of supporting elevated NAD+ levels for better health and vitality,” said Uladzimir Seuruk<\/a>, Founder & CEO of Cata-Kor. “With this transition, we are introducing a groundbreaking new formula, enhanced technology, and a stronger commitment to quality.”<\/p>\n

As part of the rebrand, Cata-Kor is unveiling a revamped formula that eliminates Nicotinamide Riboside (NR) and Quercetin, replacing them with patented LipoNAD+ and Resveratrol. The exclusive LipoNAD+ technology features a lipid-coated delivery system that bypasses stomach breakdown and is more readily absorbed in the intestines, optimizing cellular energy production and repair. Additionally, Cata-Kor is reinforcing its commitment to quality and transparency by shifting to 100% U.S.-based production, ensuring every supplement meets the highest safety and manufacturing standards.<\/p>\n

Despite these changes, Cata-Kor<\/a> remains dedicated to its core mission. The supplement continues to elevate NAD+ levels, supporting energy, longevity, and cellular health. The formula remains scientifically backed, with each serving delivering 500 mg of active ingredients for optimal results. Cata-Kor products will continue to be available on TikTok Shop and Amazon, ensuring accessibility for health-conscious consumers.<\/p>\n

Leading this transformation is Seuruk, the pioneering researcher behind the brand. While the name has evolved, Cata-Kor’s<\/a> signature packaging and recognizable product color remain unchanged, maintaining continuity and trust with its customers.<\/p>\n

This rebranding marks a pivotal moment in longevity science, reinforcing Cata-Kor’s commitment to cutting-edge innovation and consumer trust.<\/p>\n

For more information, visit https:\/\/catakor.com<\/a>.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Otter PR<\/a>
Contact Person:<\/strong> Mark Hashem
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 7274339069
Address:<\/strong>100 E Pine St Suite 110
City:<\/strong> Orlando
State:<\/strong> Florida
Country:<\/strong> United States
Website:<\/strong> OtterPR.com<\/a><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Pioneering the Future of NAD+ Supplementation with Advanced LipoNAD+ Technology and a Renewed Commitment to Scientific Excellence. Miami, FL – Mar 5, 2025 – Reus Research, a leader in NAD+ supplementation and longevity science, is officially rebranding as Cata-Kor, marking … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,434,405,406,404],"tags":[],"class_list":["post-734506","post","type-post","status-publish","format-standard","hentry","category-Business","category-Fashion-Beauty","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/734506","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=734506"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/734506\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=734506"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=734506"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=734506"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}